<DOC>
	<DOCNO>NCT02235870</DOCNO>
	<brief_summary>This pivotal trial Obalon Balloon System intend generate safety effectiveness data require support future marketing application . The trial design evaluate 6-month use Obalon Balloon System adjunct nutrition lifestyle behavior modification program . Weight loss evaluate 6-month course determine specific predefined superiority margin achieve device group compare sham-control group .</brief_summary>
	<brief_title>Obalon Balloon System Pivotal IDE ( SMART ) Trial</brief_title>
	<detailed_description />
	<criteria>1 . Male female age 2264 year 2 . Current BMI 30.0 40 kg/m2 3 . Previously attempt lose weight unsuccessfully use medically supervise nonmedically supervise diet 4 . Willing attend protocolspecified followup visit plus additional followup visit require throughout entire study period 5 . Willing avoid noncommercial air travel scuba dive entire study period 6 . Willing avoid medication substance know effect weight change study 7 . Willing avoid NonSteroidal Antiinflammatory Drugs ( NSAIDs ) medication know gastric irritant study 8 . Willing use contraception avoid pregnancy study subject female child bear potential 9 . Willing provide write informed consent 1 . Significant weight loss past 12 month 2 . Use medication substance know induce weight gain weight loss 3 . Participation clinical study start trial last year 4 . Known history endocrine disorder affect weight 5 . Currently receive chronic steroid immunosuppressive therapy previously diagnose HIV 6 . Subjects diagnose bulimia , binge eating , compulsive overeating , high liquid calorie intake habit similar eat related psychological disorder 7 . Intent undergo gastric surgery gastric band study period within 6 month period completion study 8 . Prior use weight loss medical device 9 . Known history structural functional disorder esophagus 10 . Known history structural functional disorder esophagus , include swallow disorder , esophageal chest pain disorder , drug refractory esophageal reflux symptom 11 . Known history structural functional disorder stomach 12 . Known history structural functional disorder stomach , include symptom chronic upper abdominal pain , chronic nausea , chronic vomiting , chronic dyspepsia symptom suggestive gastroparesis , include postprandial fullness pain , postprandial nausea vomit early satiety 13 . Known history duodenal ulcer , intestinal diverticulum ( diverticulitis ) , intestinal varix , intestinal stricture/stenosis , small bowel obstruction , obstructive disorder gastrointestinal ( GI ) tract 14 . Currently ongoing symptom suggestive intermittent small bowel obstruction , recurrent bout postprandial abdominal pain , nausea vomit 15 . Known history irritable bowel syndrome , radiation enteritis inflammatory bowel disease , Crohn 's disease 16 . Known history GI surgery may result anatomical GI tract abnormalities 17 . Type 1 diabetes 18 . Type 2 diabetes require insulin hypoglycemic oral agent . 19 . Experienced myocardial infarction , know history angina , know history congestive heart failure , currently medically treat cardiac condition 20 . Poorly control hypertension , ( ≥ 160 mmHg Systolic ≥ 100mmHg Diastolic ) . 21 . End stage renal disease require hemodialysis within past 6 month 22 . Unwilling unable avoid NonSteroidal AntiInflammatory Drugs ( NSAIDs ) , include Aspirin , Diclofenac , Ibuprofen , Naproxen , medication know gastric irritant begin two week prior enrollment throughout entire study period 23 . Subjects take medication specify hourly interval may affect change gastric empty 24 . Subjects require use antiplatelet drug agent affect normal clot blood 25 . Untreated unstable alcohol illicit drug addiction 26 . Known history allergy component device material 27 . Currently pregnant breastfeeding intention become pregnant study 28 . Life expectancy less 1 year severe renal , hepatic , pulmonary medical condition , opinion investigator 29 . Subject employed investigator , close relative investigator , investigator 's staff 30 . Subject close relative another subject already enrol study . 31 . Any condition , opinion investigator , would interfere subject participation , may confound study result , interfere compliance study ( e.g. , psychosocial issue ) .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Weight Loss</keyword>
	<keyword>Obesity</keyword>
	<keyword>BMI</keyword>
</DOC>